Adapthealth CORP Form 4 insider transactions

Kenneth A Samet, a Director of AdaptHealth Corp., purchased 23,500 shares of common stock on August 6, 2026 for $6.38 per share.

Dale B Wolf, a Director of AdaptHealth Corp., purchased 40,000 shares of common stock on August 6, 2026.

AdaptHealth Corp. Chief Commercial Officer Russell E. Schuster III has sold 11,275 shares of common stock for $10.44 per share, executed automatically under a pre-established Rule 10b5-1 trading plan.

AdaptHealth Corp. director David Solomon Williams III reported the acquisition of 18,999 restricted stock units on June 24, 2026.

AdaptHealth Corp. director Susan T. Weaver reported the acquisition of 18,999 common stock shares, valued at $0, and now beneficially owns 73,472 shares.

AdaptHealth Corp. director Gregory Belinfanti acquired 18,999 shares of common stock through restricted stock units.

Bradley J. Coppens, a Director at AdaptHealth Corp., reported transactions involving common stock and restricted stock units.

AdaptHealth Corp. reports a transaction where Director Theodore B. Lundberg acquired 18,999 shares of common stock.

AdaptHealth Corp. Director Dale B. Wolf acquired 18,999 shares of common stock, with some held indirectly through a trust.

AdaptHealth Corp. director Kenneth A. Samet acquired shares through restricted stock units and a purchase, increasing his beneficial ownership.

AdaptHealth Corp. Chief Commercial Officer Russell E. Schuster III sold 11,275 shares of common stock via a Rule 10b5-1 plan.

AdaptHealth Corp. Chief Operating Officer Daniel Edward McFadden acquired 20,134 restricted stock units.

AdaptHealth Corp. Chief Technology Officer Albert Prast filed an amendment to correct an overstatement of 135,443 shares in previous ownership filings.

One Equity Partners entities, including a 10% owner and director, increased their beneficial ownership in AdaptHealth Corp. through recent common stock purchases.

One Equity Partners entities, including OEP VII GP, L.L.C., amended a filing to reflect significant common stock purchases in AdaptHealth Corp. totaling over 2 million shares.

AdaptHealth Corp. Director and 10% owner Richard M. Cashin, through affiliated entities, acquired over 447,000 shares of common stock.

AdaptHealth's Chief Technology Officer, Albert A. Prast, exercised stock options and increased his direct beneficial ownership of common stock.

Richard M. Cashin Jr., a Director and 10% owner of AdaptHealth Corp., acquired over 2 million shares of common stock totaling approximately $20 million through a Rule 10b5-1 plan.

AdaptHealth Corp. Director Dale B. Wolf purchased 8,000 shares of common stock at an average price of $8.96 per share.

AdaptHealth Corp.'s CLO and General Counsel, Richard W. Rew II, acquired 5,000 shares of common stock at $8.91 per share.

AdaptHealth Corp.'s CLO and General Counsel, Richard W. Rew II, acquired 53,688 restricted stock units, increasing his beneficial ownership to 102,097 shares.

AdaptHealth's Chief Commercial Officer, Russell E. Schuster III, received a grant of 48,807 restricted stock units, aligning executive incentives with shareholder interests.

AdaptHealth's Chief Operating Officer, Toby Scott Barnhart, was granted 68,330 restricted stock units, aligning executive incentives with shareholder value.

AdaptHealth Corp.'s Chief Technology Officer, Albert A. Prast, acquired 63,449 restricted stock units of common stock.

AdaptHealth's Chief Business Systems Officer, Daniel McFadden, acquired 29,284 restricted stock units, increasing his beneficial ownership to 83,242 shares.

AdaptHealth Corp. CEO Suzanne Foster received a grant of 329,449 restricted stock units, increasing her total beneficial ownership to 924,050 shares.

AdaptHealth's Chief Accounting Officer, Christine E. Archbold, was granted 32,213 restricted stock units, increasing her direct beneficial ownership to 107,198 shares.

AdaptHealth Corp.'s Chief Financial Officer, Jason A Clemens, was granted 126,899 restricted stock units, increasing his direct beneficial ownership.

AdaptHealth Corp. Director Theodore B. Lundberg acquired 13,740 restricted stock units, increasing his total beneficial ownership to 873,496 shares.

AdaptHealth Director Gregory Belinfanti acquired 11,776 restricted stock units, increasing his direct beneficial ownership to 85,270 shares.